Filing Details
- Accession Number:
- 0000878526-18-000060
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-09 17:25:20
- Reporting Period:
- 2018-05-07
- Accepted Time:
- 2018-05-09 17:25:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 878526 | Natus Medical Inc | BABY | Electromedical & Electrotherapeutic Apparatus (3845) | 770154833 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221306 | Christopher Chune Dong Chung | C/O Natus Medical Incorporated 6701 Koll Center Parkway, Suite 120 Pleasanton CA 94566 | Vice President Medical Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value Per Share | Acquisiton | 2018-05-07 | 15,358 | $10.69 | 151,731 | No | 4 | M | Direct | |
| Common Stock, $0.001 Par Value Per Share | Disposition | 2018-05-07 | 15,358 | $33.32 | 136,373 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Nonqualified Stock Option | Disposition | 2018-05-07 | 15,358 | $10.69 | 15,358 | $10.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2012-07-07 | 2018-06-07 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $33.30 to $33.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
